Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status
- PMID: 9269430
- DOI: 10.1007/978-1-4615-5865-1_26
Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status
Abstract
The presence and significance of tumor hypoxia has been recognized since the 1950's. Hypoxic cells in vitro and in animal tumors in vivo are documented to be three times more resistant to radiation-induced killing compared to aerobic cells. There is now evidence that tumor hypoxia is treatment-limiting in many human cancers. One common way to describe the extent of hypoxia in individual and groups of tumors is the "hypoxic fraction." This measurement infers that cells are present in only two radiobiologically significant states: oxygenated and hypoxic. In this paper, we demonstrate the qualitative and quantitative presence of hypoxic tumor cells using the oxygen dependent metabolism of the 2-nitroimidazole, EF5. Two assumptions concerning the calculation and interpretation of the hypoxic fraction are considered. The first is the use of multiple animals to describe the radiation response at a given radiation dose. We hypothesize that the presence of intertumor variability in radiation response due to hypoxia could negatively influenced the characterization of the change in slope required to calculate the hypoxic fraction. The studies presented herein demonstrate heterogeneity of radioresponse due to hypoxic fraction within and between tumor lines. The 9L subcutaneous tumor studied in air-breathing rats demonstrates a 2 log variation in surviving fraction at 17 Gy. The Morris 7777 hepatoma, in contrast, showed little variability of radiation response. Our second question addresses the limitations of using the "hypoxic fraction" to describe the radiation response of a tumor. This calculated value infers that radiobiological hypoxia is a binary measurement: that a tumor contains two cell populations, aerobic cells with maximal radiosensitivity and hypoxic cells with maximal radioresistance. The classic work of Thomlinson and Gray, however, implies the presence of an oxygen gradient from tumors vessel through the tissues. In both the 9L and Q7 tumors, flow cytometric analysis of EF5 binding demonstrates a continuous range of cellular pO2 levels. These studies suggest that: 1) there is extensive intertumor variability of radiation response in certain tumor lines; 2) the variability in radiation response between individual tumors in a group may affect the ability to describe a particular tumor type's "hypoxic fraction" and 3) The oxygen status of tumor cells is a continuum. This realization affects the ability to apply a binary concept such as the "hypoxic fraction" effectively in radiobiology.
Similar articles
-
2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.Cancer Res. 1996 Jan 15;56(2):405-11. Cancer Res. 1996. PMID: 8542599
-
Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.Int J Cancer. 1996 Jul 29;67(3):372-8. doi: 10.1002/(SICI)1097-0215(19960729)67:3<372::AID-IJC11>3.0.CO;2-A. Int J Cancer. 1996. PMID: 8707411
-
Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):1005-17. doi: 10.1016/s0360-3016(99)00342-9. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705024
-
Misonidazole and other hypoxia markers: metabolism and applications.Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1195-202. doi: 10.1016/0360-3016(86)90257-9. Int J Radiat Oncol Biol Phys. 1986. PMID: 3528089 Review.
-
Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5.Methods Enzymol. 2002;352:3-31. doi: 10.1016/s0076-6879(02)52003-6. Methods Enzymol. 2002. PMID: 12125356 Review.
Cited by
-
Impact of anemia in patients with head and neck cancer treated with radiation therapy.Curr Treat Options Oncol. 2005 Jan;6(1):31-45. doi: 10.1007/s11864-005-0011-4. Curr Treat Options Oncol. 2005. PMID: 15610713 Review.
-
Prognostic Factors and Long-Term Outcome Prediction in Patients with Hypopharyngeal Carcinoma Treated with (Chemo)radiotherapy: Development of a Prognostic Model.Biomedicines. 2025 Feb 9;13(2):417. doi: 10.3390/biomedicines13020417. Biomedicines. 2025. PMID: 40002830 Free PMC article.
-
Hypoxia Imaging As a Guide for Hypoxia-Modulated and Hypoxia-Activated Therapy.Antioxid Redox Signal. 2022 Jan;36(1-3):144-159. doi: 10.1089/ars.2021.0176. Antioxid Redox Signal. 2022. PMID: 34428981 Free PMC article. Review.
-
Influence of chronic hypoxia and radiation quality on cell survival.J Radiat Res. 2013 Jul;54 Suppl 1(Suppl 1):i13-22. doi: 10.1093/jrr/rrs135. J Radiat Res. 2013. PMID: 23824117 Free PMC article.
-
Influence of acute hypoxia and radiation quality on cell survival.J Radiat Res. 2013 Jul;54 Suppl 1(Suppl 1):i23-30. doi: 10.1093/jrr/rrt065. J Radiat Res. 2013. PMID: 23824123 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources